People attack Pharmaceuticals and can’t Understand why they Get Out of the Drug-Making Business

Posted by PITHOCRATES - April 21st, 2013

Week in Review

Everyone hates the pharmaceuticals.  Because they don’t make life-saving drugs cheap enough.  And they don’t bring them to market quickly enough.  But when people need a new antibiotic that can take on a superbug who do they come running to?  Those evil and vile pharmaceuticals.  And they beg them to do what no one else can.  Save lives by bringing new drugs to market.  Of course when they do rush a drug to market and it hurts some people then everyone hates the pharmaceuticals.  For not taking the time to make sure the drug was safe before rushing it to market.  Just to make a buck.

Pharmaceuticals just can’t win.  They’re damned if they do.  And damned if they don’t.  It’s a wonder any of them stay in the business (see Antibiotic progress on superbugs called ‘alarmingly slow’ posted 4/21/2013 on CBC News).

Both biological and economic factors hinder the development of new antibiotics, Murray said. Yet new drugs are needed for resistant infections that continue to increase in frequency, causing significant illness and mortality, the society noted…

Wright’s team has some promising leads on potential antibiotics, but they can’t find a drug company willing to spend the money to get the drugs to market.

“Funding is the challenging thing,” Wright lamented.

The infectious disease society found that most of the large drug companies have left the antibiotic business. The group has proposed tax credits to encourage the remaining pharmaceutical companies to conduct the expensive clinical trials needed to test antibiotic candidates…

“One would like to think that the pharmaceutical industry has motives in mind that are to benefit health care and human kind in general. Sadly, I think their bottom line is a business,” said Simor, who has no shares or interest in the pharmaceutical industry.

Expensive clinical trials?  What, you mean they weren’t lying when they say it takes a lot of money to bring a new drug to market?  If so why are we always accusing them of charging too much for their drugs?  I mean, someone has to pay for all of those lawsuits.  As well as those clinical trials.  And there is only one thing that can.  The price per pill.

Yes, they are more concerned about their bottom line than benefitting human kind.  Because they can’t force their highly skilled people to work for free.  Most countries have labor laws against that sort of thing.  And because they have to pay for these people years before they can sell any drugs they are working on someone has to pay them in the mean time.  And these people are investors.  Who take the risk of paying people for years of work even though what they’re working on may be nothing but a dead-end that produces no revenue.  Which happens a lot.  So the drugs that actually make it to market have to pay for themselves.  And all of those dead-ends.

Capitalism makes those miracle drugs possible.  And the proof of that is that they need these drug companies to bring these drugs to market.  For the state cannot.  Because the state doesn’t know anything about risk taking.  The only thing they know is how to raise taxes to pay for an inefficient bureaucracy.  While a private drug company knows how to get an investor to pay for an efficient business plan.  Capitalism brings new drugs to market.  And when you attack capitalism too much (higher taxes, more regulations, no relief from frivolous lawsuits, etc.) those who wish to make a profit may get out of the drug-making business.

www.PITHOCRATES.com

Share

Tags: , , , , , , ,

Comments are closed.

Blog Home